by adminTorusBrand | Nov 8, 2016 | Axim Biotechnologies, Company News
Medical Marijuana, Inc. announced this week that AXIM® Biotechnologies secured the necessary private funding needed to continue its pharmaceutical clinical trials program in the development of cannabinoid medications for multiple medical indications. On news of AXIM®...
by adminTorusBrand | Nov 1, 2016 | Axim Biotechnologies, Company News
[vc_row][vc_column][vc_column_text]The premier educational and networking event for investment professionals, the MoneyShow was created to address the concerns of modern investors. At this month’s MoneyShow Dallas, there was great interest surrounding the cannabis...
by adminTorusBrand | Oct 31, 2016 | Company News, HempMeds
[vc_row][vc_column][vc_column_text]From time to time, we come across families who have found a way to generously give back to their community at large, despite their own complicated circumstances. These families have a special place in our hearts, especially because...
by adminTorusBrand | Oct 25, 2016 | Company News
[vc_row][vc_column][vc_column_text]Medical Marijuana, Inc. has dedicated itself to the monumental task of bringing access to cannabinoids to everyone in the world, regardless of geographical location, financial means, or local laws. To complete this mission, Medical...
by adminTorusBrand | Oct 21, 2016 | Company News, Dr. Titus Insights, Scientific Research
This week: Many Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) are now Associated with Heart Failure Cannabis Flavonoids – Emerging Therapeutic Applications Marijuana Arrests Fall to a 20 Year Low Autism Patents Now Treating Children with Cannabis Many Non-Steroidal...
by adminTorusBrand | Oct 19, 2016 | Axim Biotechnologies, Company News
[vc_row][vc_column][vc_column_text]If there is a central issue holding back the expansion of legal medical cannabis in America, it is a perceived lack of research. It is the refrain rising up out of the throats of all opponents to cannabis legalization. Lack of...
